Skip to main content

2022 Canadian Cardiovascular Congress Main banner

Tweets by 2022 Canadian Cardiovascular Congress

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

In Person Event

Livestream

On Demand

Ticketed Event

Back

Anique Ducharme

Canada

Novartis Pharmaceuticals Canada Inc. (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)

Poster(s):

(P103) EFFECTIVENESS, SAFETY, AND TOLERABILITY OF SACUBITRIL/VALSARTAN OVER 3 YEARS OF FOLLOW-UP IN CANADIAN PRACTICE: INSIGHTS FROM THE PARTHENON REGISTRY
Friday, October 28, 2022
1:30 PM – 1:40 PM EDT